The authors showed that highly purified CD34+ CD38- cells but not CD34- or CD34+/CD38+ cells from AML patient-derived xenograft (PDX) samples could efficiently repopulate AML in mice. This evidence concerns the gene CD38 and acute myeloid leukemia.